Author: United States. Army. General Hospital No. 21 (1918- )Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Standardization of Diets and a Resumé of Treatment in Tuberculosis
Author: United States. Army. General Hospital No. 21 (1918- )Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
The Boston Medical and Surgical Journal
Author: Journal of the American Medical Association
Author: American Medical AssociationPublisher:
ISBN:
Category : Electronic journals
Languages : en
Pages : 980
Book Description
Boston Medical and Surgical Journal
Author: Treatment of Tuberculosis
Author: World Health OrganizationPublisher:
ISBN:
Category : Medical
Languages : en
Pages : 60
Book Description
Understanding Tuberculosis and its Control
Author: Helen MacdonaldPublisher: Routledge
ISBN: 0429853726
Category : Social Science
Languages : en
Pages : 422
Book Description
Over the last two decades, attempts to control the problem of tuberculosis have become increasingly more complex, as countries adopt and adapt to evolving global TB strategies. Significant funding has also increased apace, diagnostic possibilities have evolved, and greater attention is being paid to developing broader health systems. Against this background, this book examines tuberculosis control through an anthropological lens. Drawing on ethnographic case studies from China, India, Nepal, South Africa, Romania, Brazil, Ghana and France, the volume considers: the relationship between global and national policies and their unintended effects; the emergence and impact of introducing new diagnostics; the reliance on and use of statistical numbers for representing tuberculosis, and the politics of this; the impact of the disease on health workers, as well as patients; the rise of drug-resistant forms; and issues of attempted control. Together, the examples showcase the value of an anthropological understanding to demonstrate the broader bio-political and social dimensions of tuberculosis and attempts to deal with it.
WHO consolidated guidelines on drug-resistant tuberculosis treatment
Author: World Health OrganizationPublisher: World Health Organization
ISBN: 9789241550529
Category : Medical
Languages : en
Pages : 0
Book Description
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
Author: 
Author: 
Author: